|
HY-132840-5mg
|
MedChemexpress LLC
|
Sovilnesib [CAS 2410796-79-9]
|
|
Cancer-programmed cell death
|
|
|
HY-132840-50mg
|
MedChemexpress LLC
|
Sovilnesib [CAS 2410796-79-9]
|
|
Cancer-programmed cell death
|
|
|
HY-132840-1mL
|
MedChemexpress LLC
|
Sovilnesib [CAS 2410796-79-9] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-129589-1mg
|
MedChemexpress LLC
|
Thailanstatin A [CAS 1426953-21-0]
|
|
Cancer-programmed cell death
|
|
|
HY-129589-5mg
|
MedChemexpress LLC
|
Thailanstatin A [CAS 1426953-21-0]
|
|
Cancer-programmed cell death
|
|
|
HY-135572-10mg
|
MedChemexpress LLC
|
TLX agonist 1 [CAS 958323-31-4]
|
|
Cancer-programmed cell death
|
|
|
HY-135572-100mg
|
MedChemexpress LLC
|
TLX agonist 1 [CAS 958323-31-4]
|
|
Cancer-programmed cell death
|
|
|
HY-135572-25mg
|
MedChemexpress LLC
|
TLX agonist 1 [CAS 958323-31-4]
|
|
Cancer-programmed cell death
|
|
|
HY-135572-5mg
|
MedChemexpress LLC
|
TLX agonist 1 [CAS 958323-31-4]
|
|
Cancer-programmed cell death
|
|
|
HY-135572-50mg
|
MedChemexpress LLC
|
TLX agonist 1 [CAS 958323-31-4]
|
|
Cancer-programmed cell death
|
|
|
HY-135572-1mL
|
MedChemexpress LLC
|
TLX agonist 1 [CAS 958323-31-4] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-50935-10mg
|
MedChemexpress LLC
|
Troglitazone [CAS 97322-87-7]
|
|
Cancer-programmed cell death
|
|
|
HY-50935-100mg
|
MedChemexpress LLC
|
Troglitazone [CAS 97322-87-7]
|
|
Cancer-programmed cell death
|
|
|
HY-50935-5mg
|
MedChemexpress LLC
|
Troglitazone [CAS 97322-87-7]
|
|
Cancer-programmed cell death
|
|
|
HY-50935-50mg
|
MedChemexpress LLC
|
Troglitazone [CAS 97322-87-7]
|
|
Cancer-programmed cell death
|
|
|
HY-50935-1mL
|
MedChemexpress LLC
|
Troglitazone [CAS 97322-87-7] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-50935S-1mg
|
MedChemexpress LLC
|
Troglitazone-d4 [CAS 2749370-85-0]
|
|
Cancer-programmed cell death
|
|
|
HY-117997-1mg
|
MedChemexpress LLC
|
UMB-32 [CAS 1635437-39-6]
|
|
Cancer-programmed cell death
|
|
|
HY-100748-1mg
|
MedChemexpress LLC
|
Zabadinostat [CAS 934828-12-3]
|
|
Cancer-programmed cell death
|
|
|
HY-100748-10mg
|
MedChemexpress LLC
|
Zabadinostat [CAS 934828-12-3]
|
|
Cancer-programmed cell death
|
|
|
HY-100748-100mg
|
MedChemexpress LLC
|
Zabadinostat [CAS 934828-12-3]
|
|
Cancer-programmed cell death
|
|
|
HY-100748-5mg
|
MedChemexpress LLC
|
Zabadinostat [CAS 934828-12-3]
|
|
Cancer-programmed cell death
|
|
|
HY-100748-50mg
|
MedChemexpress LLC
|
Zabadinostat [CAS 934828-12-3]
|
|
Cancer-programmed cell death
|
|
|
HY-100748-1mL
|
MedChemexpress LLC
|
Zabadinostat [CAS 934828-12-3] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
ATGP3891-100ug
|
NKMax Bio (ATGen)
|
SPARC-like 1/SPARCL1 [17-650 a.a.], Recombinant Protein
|
Mouse
|
SDS-PAGE
|
|
